Your experience on our website is key to advancing this platform - share your valuable insights by taking part in our online survey after your visit: Click here to participate. Duration: 7-10min.

Support making RiG more international!

Take part in our online survey at the end of your visit and share your valuable experiences and opinions. Duration: 7-10 min.

Start survey

The Biomedical Center Munich (BMC) at Ludwig-Maximilians-Universitaet (LMU) Munich is a leading research center for biomedical sciences, including cardiovascular research, neuroscience, and molecular biology. It is home to about 60 research groups with approximately 450 employees working in the field of applied cell sciences. 

The BMC is a central element in the LMU’s strategy for close integration and translation of biomedical research and patient care. Combining preclinical, clinical-theoretical and clinical institutes and chairs, BMC research is committed to bridging the divide between basic research and clinical application. 

Advancing Brain Disorder Therapies with CRISPR

How can gene editing tools be a game changer in the treatment of neurodegenerative diseases? CRISPR is widely known for genetic modifications—but its potential extends far beyond that. Professor Stefan Stricker from LMU’s Biomedical Center Munich is contributing to the REGENERAR project, a European collaboration exploring innovative CRISPR-based therapies for health conditions like Alzheimer’s and stroke.
Developing treatments for brain disorders remains a significant challenge. However, using non-viral delivery systems and epigenetic reprogramming, the REGENERAR project aims to open up new possibilities for brain regeneration.
In this interview, Professor Stricker gives an insight into CRISPR technology for neurological therapies and the challenges that lie ahead.
Click here for more information.

Exploring the Future of Cardiovascular Health

How do heart rhythm disorders develop, and what role do immune cells play in inflammation? These are the key questions driving research at the new Institute of Cardiovascular Physiology and Pathophysiology at LMU’s Biomedical Center Munich.
Cardiovascular disease remains the leading cause of death in industrialised nations. Scientists at this institute focus on the sinus node, the heart's natural pacemaker, to develop innovative treatments for heart rhythm disorders. They are also investigating how immune cells effectively fight inflammation - ensuring that the immune system responds precisely, without causing unintended damage.
Step inside the lab with our latest video! Meet the director as he shares insights into this critical global health challenge, and follow young researchers as they explore the mechanisms behind cardiac arrhythmias and controlled inflammation.
Click here for more information.

Back to all partners